Evidence map›Paper›PMID 42039147›Full record

ArticleFrontiers in cell and developmental biology2026

A TabPFN-based prediction system for refractive error and dry eye comorbidity: a retrospective study using large-scale real-world data.

Danyi Qin, Wenying Guan, Shinan Wu, Changsheng Xu, Yuwen Liu, Bing Yan, Jingyao Lv, Xiaoxin Li, Zuguo Liu

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danyi Qin *Xiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Wenying Guan *Xiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Shinan Wu *Xiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Changsheng XuXiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Yuwen LiuXiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Bing YanXiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Jingyao LvXiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Xiaoxin LiXiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Zuguo LiuXiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Eye Institute of Xiamen University, Xiamen University, Xiamen, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Refractive error and dry eye are highly prevalent ocular conditions that significantly impair the quality of life and impose a substantial burden on individuals and society. Growing evidence suggests a correlation between these two conditions. This study aimed to develop and validate a machine learning (ML) model to accurately predict the risk of concurrent dry eye comorbidities in patients with refractive error. Methods: Data from Xiamen Eye Center outpatient database (1st January 2024 to 28th February 2025) were analyzed (n = 114,579). Hyperparameter optimization, Results: Baseline characteristics were comparable between the training set and the internal test set, while significant differences were observed in multiple baseline characteristics between dry eye group and non-dry eye group among subjects with refractive error. Based on ten selected feature variables, the tabular prior-data fitted network (TabPFN) model demonstrated the best performance, showing high screening efficacy with both specificity and accuracy reaching 0.945. The interaction analysis revealed that a longer duration of refractive error was associated with a higher risk of dry eye, a relationship that was particularly pronounced among older and female patients. Furthermore, an online web calculator was developed to deploy this diagnostic prediction model. Discussion: This study developed a high-performance and interpretable ML system based on a large-scale real-world clinical dataset for the early prediction of concurrent dry eye risk in patients with refractive error. The system holds significant potential as a predictive aid for clinical decision-making, enabling more timely and personalized patient management, thereby offering substantial clinical value and promising application prospects.

Indexed as

artificial intelligenceclinical decision systemdry eyemachine learningrefractive error

Identifiers

PMID42039147
PMCPMC13102667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.